anti-VEGF protein therapeutic (Ocular Therapeutix)

N/A

Report date: 2025/01/26 16:48:07

Base Information

Drug Nameanti-VEGF protein therapeutic (Ocular Therapeutix)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsDiabetic macular oedemaRetinal Vein OcclusionWet age-related macular degeneration +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOcular Therapeutix Inc
China Registration ClassN/A

Develop Information

Active CompaniesOcular Therapeutix Inc
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaRetinal Vein OcclusionWet age-related macular degeneration
Inactive IndicationsRetinal Diseases

Other Information

ATC CodeN/A
Related LinksN/A